financetom
Business
financetom
/
Business
/
What's Going On With Rivian (RIVN) Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Rivian (RIVN) Stock?
Jul 11, 2024 12:32 PM

Rivian Automotive Inc ( RIVN ) shares are trading higher by 3.1% to $16.88 Thursday afternoon. Shares of EV-related stocks are trading higher following recent CPI Data. Additionally, the Department of Energy disclosed a $1.7 billion investment to transform 11 auto facilities that are either shut down or at risk into electric vehicle manufacturing plants and supply chain hubs.

The cooling inflation increases the likelihood that the Federal Reserve will cut interest rates sooner rather than later. Lower interest rates reduce the cost of borrowing. Rivian, being a relatively new and capital-intensive company, relies on borrowing to fund its operations and growth.

Cheaper borrowing costs would reduce Rivian’s financial expenses, potentially improving its financial health and making its stock more attractive.

Lower inflation and potential rate cuts can also lead to increased consumer spending power. As borrowing becomes cheaper, consumers are more likely to finance big-ticket purchases such as electric vehicles. This could drive up demand for Rivian's products, positively impacting sales and revenue growth.

Read Also: Biden Cheers Inflation Progress, Rate Cut Chorus Grows Louder Among 5 Economists

How To Buy RIVN Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Rivian Automotive’s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, RIVN has a 52-week high of $28.06 and a 52-week low of $8.26.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BeyondSpring Says First Patient Dosed in Phase 2 Trial of Lung Cancer Combination Treatment
BeyondSpring Says First Patient Dosed in Phase 2 Trial of Lung Cancer Combination Treatment
Mar 25, 2024
10:28 AM EDT, 03/25/2024 (MT Newswires) -- BeyondSpring ( BYSI ) said Monday that the first patient has been dosed in a phase 2 investigator-initiated trial of pembrolizumab, plinabulin plus etoposide/platinum for first-line extensive-stage small-cell lung cancer, or ES-SCLC. The study, conducted in China, will evaluate the efficacy and safety of this drug combination in first-line ES-SCLC. The primary endpoint...
LanzaTech Global, Technip Energies Selected by DOE for $200 Million Award Negotiations
LanzaTech Global, Technip Energies Selected by DOE for $200 Million Award Negotiations
Mar 25, 2024
10:26 AM EDT, 03/25/2024 (MT Newswires) -- LanzaTech Global ( LNZA ) and Technip Energies said Monday they have been chosen by the US Department of Energy to start the negotiations process for up to $200 million in funding as part of the Industrial Demonstrations Program. The company said the Sustainable Ethylene from CO2 Utilization with Renewable Energy, or SECURE,...
Syros Pharmaceuticals Completes Enrollment of 190 People in Phase 3 Trial of Tamibarotene
Syros Pharmaceuticals Completes Enrollment of 190 People in Phase 3 Trial of Tamibarotene
Mar 25, 2024
10:27 AM EDT, 03/25/2024 (MT Newswires) -- Syros Pharmaceuticals ( SYRS ) said Monday it completed the enrollment of 190 people in a phase 3 trial assessing tamibarotene, which is intended to treat higher-risk myelodysplastic syndrome in patients with RARA gene overexpression. The initial group of 190 people is needed to back the trial's complete response primary endpoint analysis, the...
Fisker Stock Hits Record Low: Automaker Terminates Transaction Discussions
Fisker Stock Hits Record Low: Automaker Terminates Transaction Discussions
Mar 25, 2024
Fisker Inc ( FSR ) shares are trading lower by 28% to $0.09 and are halted during Monday’s session after the company announced it received notice from the large automaker with which the company had been in negotiations for a potential transaction that the automaker terminated the negotiations. Consequently, Fisker ( FSR ) early Monday said the company is exploring...
Copyright 2023-2026 - www.financetom.com All Rights Reserved